Signaturefd, LLC Syros Pharmaceuticals, Inc. Transaction History

Signaturefd, LLC

  • $5.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 25, 2022
SELL
$3.26 - $4.66 $652 - $932
-200 Closed
0 $0
Q3 2021

Oct 28, 2021
BUY
$4.08 - $5.66 $118 - $164
29 Added 16.96%
200 $1,000
Q2 2021

Jul 26, 2021
BUY
$5.01 - $7.48 $856 - $1,279
171 New
171 $1,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email